Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,814

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Pre-eclampsia

Sibai, Baha, Dekker, Gus, Kupferminc, Michael·2005·The Lancet
DOI 10.1016/s0140-6736(05)17987-2
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(05)17987-2

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 135

  1. Report of the National High Blood Pressure Education Program, 2000, Working group report on high blood pressure in pregnancy, Am J Obstet Gynecol, 183, S1, 10.1067/mob.2000.107928 · DOI · Paper page
  2. Sibai, 2003, Diagnosis and management of gestational hypertension and preeclampsia, Obstet Gynecol, 102, 181, 10.1016/S0029-7844(03)00475-7 · DOI · Paper page
  3. Ness, 1996, Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications, Am J Obstet Gynecol, 175, 1365, 10.1016/S0002-9378(96)70056-X · DOI · Paper page
  4. Vatten, 2004, Is pre-eclampsia more than one disease?, BJOG, 111, 298, 10.1111/j.1471-0528.2004.00071.x · DOI · Paper page
  5. Sibai, 1998, Prevention of preeclampsia: a big disappointment, Am J Obstet Gynecol, 179, 1275, 10.1016/S0002-9378(98)70146-2 · DOI
  6. Dekker, 2001, Primary, secondary, and tertiary prevention of pre-eclampsia, Lancet, 357, 209, 10.1016/S0140-6736(00)03599-6 · DOI · Paper page
  7. Hauth, 2000, Pregnancy outcomes in healthy nulliparous women who subsequently developed hypertension, Obstet Gynecol, 95, 24, 10.1016/S0029-7844(99)00462-7 · DOI · Paper page
  8. Conde-Agudelo, 2004, World Health Organization systematic review of screening tests for preeclampsia, Obstet Gynecol, 104, 1367, 10.1097/01.AOG.0000147599.47713.5d · DOI · Paper page
  9. Harlow, 2001, The diversity of diagnosis of preeclampsia, Hypertens Pregnancy, 20, 57, 10.3109/10641950109152642 · doi:10.3109/10641950109152642
  10. Brown, 2000, The detection, investigation and management of hypertension in pregnancy: executive summary, Aust N Z J Obstet Gynaecol, 40, 133, 10.1111/j.1479-828X.2000.tb01136.x · DOI · Paper page
  11. Brown, 2001, The classification and diagnosis of the hypertensive disorders of pregnancy: a statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP), Hypertens Pregnancy, 20, IX, 10.3109/10641950109152635 · DOI · Paper page
  12. Duley, 2003, Pre-eclampsia and the hypertensive disorders of pregnancy, Br Med Bull, 67, 161, 10.1093/bmb/ldg005 · DOI · Paper page
  13. Caritis, 1998, Low-dose aspirin to prevent preeclampsia in women at high risk, N Engl J Med, 338, 701, 10.1056/NEJM199803123381101 · DOI · Paper page
  14. Sibai, 2002, Chronic hypertension in pregnancy, Obstet Gynecol, 100, 369, 10.1016/S0029-7844(02)02128-2 · DOI · Paper page
  15. Hnat, 2002, Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparous, Am J Obstet Gynecol, 186, 422, 10.1067/mob.2002.120280 · DOI
  16. Buchbinder, 2002, Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia, Am J Obstet Gynecol, 186, 66, 10.1067/mob.2002.120080 · DOI · Paper page
  17. Alfirevic, 2002, How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review, Eur J Obstet Gynecol Reprod Biol, 101, 6, 10.1016/S0301-2115(01)00496-1 · DOI · Paper page
  18. Kupferminc, 2003, Thrombophilia and pregnancy, Reprod Biol Endocrinol, 1, 111, 10.1186/1477-7827-1-111 · DOI · Paper page
  19. van Pampus, 1999, High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia, Am J Obstet Gynecol, 180, 1146, 10.1016/S0002-9378(99)70608-3 · DOI · Paper page
  20. Sibai, 2004, Diagnosis, controversies, and management of HELLP syndrome, Obstet Gynecol, 103, 981, 10.1097/01.AOG.0000126245.35811.2a · DOI · Paper page
  21. Zhang, 2003, Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States, Hypertens Pregnancy, 22, 203, 10.1081/PRG-120021066 · DOI · Paper page
  22. Ramsay, 2003, Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease, BJOG, 110, 1029, 10.1111/j.1471-0528.2003.02069.x · DOI
  23. Haukkamaa, 2004, Risk for subsequent coronary artery disease after preeclampsia, Am J Cardiol, 93, 805, 10.1016/j.amjcard.2003.11.065 · DOI
  24. Sattar, 2002, Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?, BMJ, 325, 157, 10.1136/bmj.325.7356.157 · DOI · Paper page
  25. Hack, 2002, Outcomes in young adulthood of very low birth-weight infants, N Engl J Med, 346, 149, 10.1056/NEJMoa010856 · DOI · Paper page
  26. Barker, 2004, The developmental origins of well-being, Philos Trans R Soc Lond B Biol Sci, 359, 1359, 10.1098/rstb.2004.1518 · DOI · Paper page
  27. Helewa, 1997, Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy, CMAJ, 157, 715
  28. Waugh, 2004, Accuracy of urinanalysis dipstick techniques in predicting significant proteinuria in pregnancy, Obstet Gynecol, 103, 769, 10.1097/01.AOG.0000118311.18958.63 · DOI
  29. Durnwald, 2003, A prospective comparison of total protein/creatinine ratio versus 24-hour urine protein in women with suspected preeclampsia, Am J Obstet Gynecol, 189, 848, 10.1067/S0002-9378(03)00849-4 · doi:10.1067/s0002-9378(03)00849-4
  30. Al, 2004, Random urine protein-creatinine ratio to predict proteinuria in new-onset mild hypertension in late pregnancy, Obstet Gynecol, 104, 367, 10.1097/01.AOG.0000134788.01016.2a · doi:10.1097/01.aog.0000134788.01016.2a
  31. Douglas, 1994, Eclampsia in the United Kingdom, BMJ, 309, 1395, 10.1136/bmj.309.6966.1395 · DOI · Paper page
  32. Sibai, 2000, Hypertensive disorders in twin versus singleton gestations, Am J Obstet Gynecol, 182, 938, 10.1016/S0002-9378(00)70350-4 · DOI · Paper page
  33. Wen, 2004, Maternal morbidity and obstetric complications in triplet pregnancies and quadruplet and higher-order multiple pregnancies, Am J Obstet Gynecol, 191, 254, 10.1016/j.ajog.2003.12.003 · DOI
  34. Einarsson, 2003, Sperm exposure and development of preeclampsia, Am J Obstet Gynecol, 188, 1241, 10.1067/mob.2003.401 · doi:10.1067/mob.2003.401
  35. Dekker, 2003, The birth interval hypothesis—does it really indicate the end of the primipaternity hypothesis?, J Reprod Immunol, 59, 245, 10.1016/S0165-0378(03)00051-2 · doi:10.1016/s0165-0378(03)00051-2
  36. Saftlas, 2003, Abortion, changed paternity, and risk of preeclampsia in nulliparous women, Am J Epidemiol, 157, 1108, 10.1093/aje/kwg101 · DOI
  37. Wang, 2002, Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia, Lancet, 359, 673, 10.1016/S0140-6736(02)07804-2 · DOI
  38. Wolfberg, 2004, Association of rheumatic disease with preeclampsia, Obstet Gynecol, 103, 1190, 10.1097/01.AOG.0000126279.87151.e1 · doi:10.1097/01.aog.0000126279.87151.e1
  39. O'Brien, 2003, Maternal body mass index and the risk of preeclampsia: a systematic overview, Epidemiology, 14, 368, 10.1097/01.EDE.0000059921.71494.D1 · DOI · Paper page
  40. Cedergren, 2004, Maternal morbid obesity and the risk of adverse pregnancy outcome, Obstet Gynecol, 103, 219, 10.1097/01.AOG.0000107291.46159.00 · DOI · Paper page
  41. Von Dadelszen, 2002, Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction?, Acta Obstet Gynecol Scand, 81, 642, 10.1034/j.1600-0412.2002.810710.x · DOI
  42. Boggess, 2003, Maternal periodontal disease is associated with an increased risk for preeclampsia, Obstet Gynecol, 101, 227, 10.1016/S0029-7844(02)02314-1 · DOI · Paper page
  43. Nilsson, 2004, The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study, BJOG, 111, 200, 10.1111/j.1471-0528.2004.00042x.x · DOI · Paper page
  44. Laivuori, 2003, Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families, Am J Hum Genet, 72, 168, 10.1086/345311 · DOI · Paper page
  45. Oudejans, 2004, The parent-of-origin effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentas, Mol Hum Reprod, 10, 589, 10.1093/molehr/gah080 · DOI
  46. Esplin, 2001, Paternal and maternal components of the predisposition to preeclampsia, N Engl J Med, 344, 867, 10.1056/NEJM200103223441201 · DOI · Paper page
  47. Lie, 1998, Fetal and maternal contributions to risk of pre-eclampsia: a population based study, BMJ, 316, 1343, 10.1136/bmj.316.7141.1343 · DOI · Paper page
  48. Skjaerven, 2002, The interval between pregnancies and the risk of preeclampsia, N Engl J Med, 346, 33, 10.1056/NEJMoa011379 · DOI · Paper page
  49. Jivraj, 2001, Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study, Hum Reprod, 16, 102, 10.1093/humrep/16.1.102 · DOI
  50. Redman, 2003, Pre-eclampsia, the placenta, and the maternal systemic inflammatory response—a review, Placenta, 24, S21, 10.1053/plac.2002.0930 · DOI · Paper page
  51. Wolf, 2001, Obesity and preeclampsia: the potential role of inflammation, Obstet Gynecol, 98, 757, 10.1016/S0029-7844(01)01551-4 · DOI · Paper page
  52. Livingston, 2001, Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia, Am J Obstet Gynecol, 185, 153, 10.1067/mob.2001.114691 · DOI
  53. Morrison, 2002, Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review, Thromb Haemost, 87, 779, 10.1055/s-0037-1613083 · DOI
  54. Chaouat, 2003, Implantation: can immunological parameters of implantation failure be of interest for pre-eclampsia?, J Reprod Immunol, 59, 205, 10.1016/S0165-0378(03)00048-2 · DOI
  55. Robertson, 2002, Transforming growth factor beta—a mediator of immune deviation in seminal plasma, J Reprod Immunol, 57, 109, 10.1016/S0165-0378(02)00015-3 · DOI · Paper page
  56. Peters, 2004, Effect of heterosexual intercourse on mucosal alloimmunisation and resistance to HIV-1 infection, Lancet, 363, 518, 10.1016/S0140-6736(04)15538-4 · DOI
  57. Khong, 1986, Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants, Br J Obstet Gynaecol, 93, 1049, 10.1111/j.1471-0528.1986.tb07830.x · DOI · Paper page
  58. Pijnenborg, 1991, Placental bed spiral arteries in the hypertensive disorders of pregnancy, Br J Obstet Gynaecol, 98, 648, 10.1111/j.1471-0528.1991.tb13450.x · DOI · Paper page
  59. Zhou, 1997, Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype, J Clin Invest, 99, 2152, 10.1172/JCI119388 · DOI · Paper page
  60. Giudice, 2002, Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation, J Clin Endocrinol Metab, 87, 2359, 10.1210/jcem.87.5.8448 · DOI
  61. Jaffe, 1995, Color Doppler imaging of the uteroplacental circulation in the first trimester: value in predicting pregnancy failure or complication, Am J Roentgenol, 164, 1255, 10.2214/ajr.164.5.7717242 · DOI
  62. Kaufmann, 2003, Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia, Biol Reprod, 69, 1, 10.1095/biolreprod.102.014977 · DOI · Paper page
  63. Martin, 1996, Scaling of the mammalian brain: the maternal energy hypothesis, News Physiol Sci, 11, 149
  64. Croy, 2003, Uterine natural killer cells; insight into their cellular and molecular biology from mouse modeling, Reproduction, 126, 149, 10.1530/rep.0.1260149 · DOI · Paper page
  65. van der Meer, 2004, Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells, Mol Hum Reprod, 189, 10.1093/molehr/gah032 · DOI
  66. Hunt, 1997, Expression of the inducible nitric oxide synthase gene in mouse uterine leukocytes and potential relationships with uterine function during pregnancy, Biol Reprod, 34, 419
  67. Dekker, 1998, Etiology and pathogenesis of preeclampsia: current concepts, Am J Obstet Gynecol, 179, 1359, 10.1016/S0002-9378(98)70160-7 · DOI · Paper page
  68. Hiby, 2004, Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success, J Exp Med, 200, 957, 10.1084/jem.20041214 · DOI · Paper page
  69. Huppertz, 1998, Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta, Histochem Cell Biol, 110, 495, 10.1007/s004180050311 · DOI · Paper page
  70. Sargent, 2003, Trophoblast deportation and the maternal inflammatory response in pre-eclampsia, J Reprod Immunol, 59, 153, 10.1016/S0165-0378(03)00044-5 · DOI · Paper page
  71. Hahn, 2002, Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia, Hum Reprod Update, 8, 501, 10.1093/humupd/8.6.501 · doi:10.1093/humupd/8.6.501
  72. Levine, 2004, Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia, Am J Obstet Gynecol, 190, 707, 10.1016/j.ajog.2003.12.019 · DOI · Paper page
  73. Ishihara, 2002, Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation, Am J Obstet Gynecol, 186, 158, 10.1067/mob.2002.119176 · DOI · Paper page
  74. Roberts, 2002, Recent Insights into the pathogenesis of pre-eclampsia, Placenta, 23, 359, 10.1053/plac.2002.0819 · DOI · Paper page
  75. Redline, 2004, Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns, Pediatr Dev Pathol, 7, 237, 10.1007/s10024-003-8083-2 · DOI · Paper page
  76. Salomon, 2003, Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy, Am J Obstet Gynecol, 189, 1517, 10.1016/S0002-9378(03)00902-5 · doi:10.1016/s0002-9378(03)00902-5
  77. Saito, 2003, Th1/Th2 balance in preeclampsia, J Reprod Immunol, 59, 161, 10.1016/S0165-0378(03)00045-7 · DOI · Paper page
  78. Mor, 2002, Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis, Biochem Pharmacol, 64, 1305, 10.1016/S0006-2952(02)01267-4 · DOI
  79. Neale, 2003, Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis, J Matern Fetal Neonatal Med, 13, 39, 10.1080/jmf.13.1.39.44 · DOI
  80. Sacks, 2003, Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells, Clin Exp Immunol, 131, 490, 10.1046/j.1365-2249.2003.02082.x · DOI
  81. Aly, 2004, Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia, Am J Obstet Gynecol, 190, 252, 10.1016/j.ajog.2003.07.003 · DOI
  82. Moretti, 2004, Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia, Am J Obstet Gynecol, 190, 1184, 10.1016/j.ajog.2003.11.008 · DOI
  83. Hung, 2004, Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia, Am J Pathol, 164, 1049, 10.1016/S0002-9440(10)63192-6 · DOI
  84. Benyo, 2001, Expression of inflammatory cytokines in placentas from women with preeclampsia, J Clin Endocrinol Metab, 86, 2505
  85. Matzinger, 2004, The danger model, Vox Sang, 87, 18, 10.1111/j.1741-6892.2004.00508.x · DOI
  86. Savvidou, 2003, Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia, Lancet, 361, 1511, 10.1016/S0140-6736(03)13177-7 · DOI · Paper page
  87. Wang, 2004, Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia, Am J Obstet Gynecol, 190, 817, 10.1016/j.ajog.2003.09.049 · DOI
  88. Redman, 1999, Preeclampsia: an excessive maternal inflammatory response to pregnancy, Am J Obstet Gynecol, 180, 499, 10.1016/S0002-9378(99)70239-5 · DOI · Paper page
  89. Roberts, 1993, Pre-eclampsia: more than pregnancy-induced hypertension, Lancet, 341, 1447, 10.1016/0140-6736(93)90889-O · DOI · Paper page
  90. Redman, 1990, Platelets and the beginnings of preeclampsia, N Engl J Med, 323, 478, 10.1056/NEJM199008163230710 · DOI
  91. Reister, 2001, Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women, Lab Invest, 81, 1143, 10.1038/labinvest.3780326 · DOI · Paper page
  92. Ashton, 2005, Uterine spiral artery remodeling involves endothelial apoptosis induced by extravillous trophoblasts through Fas/FasL interactions, Arterioscler Thromb Vasc Biol, 25, 102, 10.1161/01.ATV.0000148547.70187.89 · DOI · Paper page
  93. Rand, 2000, The annexinpathies: a new category of disease, Biochim Biophys Acta, 1498, 169, 10.1016/S0167-4889(00)00093-8 · doi:10.1016/s0167-4889(00)00093-8
  94. Shu, 2000, Immunohistochemical study of annexin V expression in placentae of preeclampsia, Gynecol Obstet Invest, 49, 17, 10.1159/000010206 · doi:10.1159/000010206
  95. Schlembach, 2003, Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction, Clin Sci, 105, 279, 10.1042/CS20030073 · doi:10.1042/cs20030073
  96. Anteby, 2004, Fetal inherited thrombophilias influence the severity of preeclampsia, IUGR and placental abruption, Eur J Obstet Gynecol Reprod Biol, 113, 31, 10.1016/j.ejogrb.2003.05.002 · DOI
  97. Chaiworapongsa, 2004, Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia, Am J Obstet Gynecol, 190, 1541, 10.1016/j.ajog.2004.03.043 · DOI · Paper page
  98. Thadhani, 2004, Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia, Hypertension, 43, 988, 10.1161/01.HYP.0000124460.67539.1d · DOI
  99. Cross, 2003, The genetics of pre-eclampsia: a feto-placental or maternal problem?, Clin Genet, 64, 96, 10.1034/j.1399-0004.2003.00127.x · DOI
  100. Tjoa, 2004, Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction, Hypertens Pregnancy, 23, 171, 10.1081/PRG-120028292 · DOI
  101. Djurovic, 2002, Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia, BJOG, 109, 759, 10.1111/j.1471-0528.2002.01330.x · DOI
  102. Chien, 2000, How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An Overview, Br J Obstet Gynaecol, 107, 196, 10.1111/j.1471-0528.2000.tb11690.x · DOI · Paper page
  103. Yu, 2003, Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation, Ultrasound Obstet Gynecol, 22, 233, 10.1002/uog.218 · DOI · Paper page
  104. Yu, 2002, Screening for pre-eclampsia and fetal growth restriction in twin pregnancies at 23 weeks of gestation by transvaginal uterine artery Doppler ultrasound, Obstet Gynecol, 20, 535
  105. Subtil, 2003, Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (part 2), BJOG, 110, 485, 10.1046/j.1471-0528.2003.t01-1-02097.x · DOI
  106. Makrides, 2001, Fish oil, and other prostaglandin precursor supplementation during pregnancy for reducing pre-eclampsia, preterm birth, low birth weight and intrauterine growth restriction, Cochrane Database Syst Rev, 4, CD003402
  107. Coomarasamy, 2003, Aspirin for prevention of preeclampsia in women with historical risk factors: a systemic review, Obstet Gynecol, 101, 1319, 10.1016/S0029-7844(03)00169-8 · DOI · Paper page
  108. Knight, 2000, Antiplatelet agents for preventing and treating pre-eclampsia, Cochrane Database Syst Rev, 2, CD000492
  109. Atallah, 2002, Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems, Cochrane Database Syst Rev, 1, CD001059
  110. North, 1995, Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease, Aust N Z J Obstet Gynaecol, 35, 357, 10.1111/j.1479-828X.1995.tb02141.x · DOI
  111. Kupferminc, 2001, Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilia, Hypertens Pregnancy, 20, 35, 10.3109/10641950109152640 · DOI
  112. Chappell, 1999, Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial, Lancet, 354, 810, 10.1016/S0140-6736(99)80010-5 · DOI · Paper page
  113. Abalos, 2001, Antihypertensive drug therapy for mild to moderate hypertension during pregnancy, Cochrane Database Syst Rev, 1, CD002252
  114. Wallenburg, 1986, Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae, Lancet, 327, 1, 10.1016/S0140-6736(86)91891-X · DOI · Paper page
  115. Coomarasamy, 2001, Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis, Obstet Gynecol, 98, 861, 10.1016/S0029-7844(01)01569-1 · DOI
  116. Coomarasamy, 2003, Individualising use of aspirin to prevent pre-eclampsia: a framework for clinical decision making, BJOG, 110, 882, 10.1111/j.1471-0528.2003.03002.x · DOI
  117. Friedman, 1999, Expectant management of severe preeclampsia remote from term, Clin Obstet Gynecol, 42, 470, 10.1097/00003081-199909000-00005 · doi:10.1097/00003081-199909000-00005
  118. Churchill, 2002, Interventionist versus expectant care for severe pre-eclampsia before term, Cochrane Database Syst Rev, 3, CD003106
  119. Vigil-DeGracia, 2003, Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation, Eur J Obstet Gynecol Reprod Biol, 107, 24, 10.1016/S0301-2115(02)00269-5 · doi:10.1016/s0301-2115(02)00269-5
  120. Haddad, 2004, Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation, Am J Obstet Gynecol, 190, 1590, 10.1016/j.ajog.2004.03.050 · DOI
  121. Weindling, 2003, The confidential enquiry into maternal and child health (CEMACH), Arch Dis Child, 88, 1034, 10.1136/adc.88.12.1034 · DOI · Paper page
  122. Magee, 1999, Fortnightly review: management of hypertension in pregnancy, BMJ, 318, 1332, 10.1136/bmj.318.7194.1332 · DOI · Paper page
  123. von Dadelszen, 2000, Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis, Lancet, 355, 87, 10.1016/S0140-6736(98)08049-0 · DOI · Paper page
  124. Rey, 1997, Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy, CMAJ, 157, 1245
  125. Magee, 2003, Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis, BMJ, 327, 1, 10.1136/bmj.327.7421.955 · DOI · Paper page
  126. Amorim, 1999, Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia, Am J Obstet Gynecol, 180, 1283, 10.1016/S0002-9378(99)70630-7 · DOI
  127. Matchaba, 2002, Corticosteroids for HELLP syndrome in pregnancy, Cochrane Database Syst Rev, 4, CD002076
  128. Heilmann, 2001, The role of intravenous volume expansion in moderate pre-eclampsia, Clin Hemorheol Microcirc, 25, 83
  129. Visser, 1995, Temporising management of severe preeclampsia with and without the HELLP syndrome, Br J Obstet Gynecol, 102, 111, 10.1111/j.1471-0528.1995.tb09062.x · DOI · Paper page
  130. Duley, 1999, Plasma volume expansion for treatment of pre-eclampsia, Cochrane Database Syst Rev, 4, CD001805
  131. Sibai, 2004, Magnesium sulfate prophylaxis in preeclampsia. Lessons learned from recent trials, Am J Obstet Gynecol, 190, 1520, 10.1016/j.ajog.2003.12.057 · DOI · Paper page
  132. Duley, 2003, Magnesium sulfate and other anticonvulsants for women with preeclampsia, Cochrane Database Syst Rev, 2, CD000025
  133. 2002, Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised, placebo-controlled trial, Lancet, 359, 1877, 10.1016/S0140-6736(02)08778-0 · DOI · Paper page
  134. Mathys, 2004, Delayed postpartum preeclampsia: an experience of 151 cases, Am J Obstet Gynecol, 190, 1464, 10.1016/j.ajog.2004.02.037 · DOI · Paper page
  135. Chames, 2002, Late postpartum eclampsia: a preventable disease?, Am J Obstet Gynecol, 186, 1174, 10.1067/mob.2002.123824 · DOI · Paper page

Cited by

See all 1,814

Metadata

Authors
Sibai, B., Dekker, G., & Kupferminc, M.
Venue
The Lancet
Publisher
Elsevier BV
Published
2005-02
Volume
365
Issue
9461
Pages
785-799
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(05)17987-2
OpenAlex
W4211054086
Cited by
1,814
References
7
FWCI
56.28
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pre-eclampsia. https://app.cochat.ai/papers/10.1016/s0140-6736(05)17987-2
The paper
Sibai, B., Dekker, G., & Kupferminc, M. (2005). Pre-eclampsia. The Lancet. https://doi.org/10.1016/s0140-6736(05)17987-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.